VeriMomБезопасен ли dihydroartemisinic acid при беременности?
No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
Related ingredients
Frequently asked questions
- Безопасен ли dihydroartemisinic acid при беременности?
- No EU Cosmetic Regulation listing (Annex II/III), no harmonised CLP classification, no SCCS or CIR safety assessment located for DHAA, and no peer‑reviewed reproductive/developmental toxicity studies on DHAA were identified. PubChem/PubChemLite and the literature describe DHAA as an artemisinin precursor but do not report reproductive hazard data for DHAA itself; therefore default hazard and mechanism scores are 0. Moderate lipophilicity (predicted logP ≈3.7, MW 236) suggests low but measurable potential for dermal absorption from a cosmetic formulation (e=1). ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- Безопасен ли dihydroartemisinic acid при грудном вскармливании?
- Same evidence base as pregnancy: no regulatory or peer‑reviewed data indicating reproductive or lactation-specific hazard for DHAA. With no data of transfer into milk for DHAA, exposure scoring follows the adult topical route (low but measurable dermal absorption, e=1). No breastfeeding‑specific studies were found. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- Безопасен ли dihydroartemisinic acid для кожи малыша?
- No infant‑specific toxicity or developmental dermatotoxicity data were found. Following your rules, because adult topical exposure is scored as measurable (e=1) and the compound is moderately lipophilic (logP ~3.7, MW 236) infant exposure is increased by +1 for immature barrier/higher SA:BW, giving e=2. Hazard and mechanism remain 0 in absence of reproductive/ED/teratogenic evidence. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/11020893?utm_source=openai))
- Как VeriMom оценивает dihydroartemisinic acid?
- VeriMom оценивает dihydroartemisinic acid в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы dihydroartemisinic acid при беременности?
- См. наш список безопасных альтернатив dihydroartemisinic acid с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.